Physician profile
Brandon J Yohn
NPI 1629417126
$1,703.08
in general payments reported to CMS, 2019-2025
17 companies · $235 in 2025
The $235 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $378 · 2020: $173 · 2021: $204 · 2022: $150 · 2023: $257 · 2024: $306 · 2025: $235.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $798.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $798.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $524.68 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $392.00 | 2019-2025 | Mounjaro, Zepbound |
| Abbvie INC. | $245.52 | 2021-2025 | Qulipta, Vraylar, Ubrelvy |
| Allergan, INC. | $161.45 | 2020 | |
| Glaxosmithkline, LLC. | $72.89 | 2022-2025 | Trelegy Ellipta |
| Abbott Laboratories | $64.64 | 2024-2025 | Freestyle Libre 3 |
| Boehringer Ingelheim Pharmaceuticals, INC. | $53.71 | 2023-2024 | Jardiance |
| Pfizer INC. | $45.66 | 2023-2025 | |
| Dynavax Technologies Corporation | $30.15 | 2024-2025 | Heplisav-B |
| Amgen INC. | $18.20 | 2024 | Evenity, Prolia |
| Astrazeneca Pharmaceuticals LP | $17.47 | 2024 | Airsupra |
| Otsuka America Pharmaceutical, INC. | $15.22 | 2025 | Rexulti |
| Antares Pharma, INC. | $14.14 | 2024 | Xyosted |
| Sanofi Pasteur INC. | $13.31 | 2024 | |
| Impel Pharmaceuticals INC. | $12.16 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $11.19 | 2020 | |
| Corium, LLC | $10.69 | 2024 | Azstarys |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brandon Yohn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.